With massive data breaches rocking industries and the public, and policymakers scrutinizing how organizations respond, it’s time to dust off policies and ensure organizations have meaningful, compliant reporting and response plans.
Project REFRESH brought the deletion of many standards and elements of performance (EP), and you will see even more changes beginning in January. This column will also review the changes to the Evidence of Standards Compliance (ESC) corrective action plan for Requirements for Improvement (RFI) that must be submitted after a survey.
HIPAA compliance and enforcement saw its share of highs and lows in 2017. As the year comes to a close, it’s a good time to look back on what your organization has learned—in terms of personal growth and lessons gleaned from other organizations.
This week’s Medicare updates include corrections to the OPPS final rule, clarification of Medicare’s policy regarding texting of patient information between healthcare providers, revisions to rural health clinic guidance, and more!
CMS' 340B FAQ reviews modifiers -JG (drug or biological acquired with 340B drug pricing program discount) and -TB (drug or biological acquired with 340B drug pricing program discount, reported for informational purposes) and requires 340B hospitals to report modifiers even on drugs that are not subject to the discount policy.
